CataloniaBio Member Cebiotex Crowdequity Round Now Live on CapitalCell: Fighting Pediatric Cancer
Cebiotex, a CataloniaBio member, has launched a new crowdequity campaign to raise €650,000 through CapitalCell in order to ensure its first drug, CEB-01 for post-op treatment of soft-tissue sarcomas, reaches pediatric oncology. The campaign is part of a larger €1.6-million round of funding; since launching, the… Read More
Read more in: Global, General News, Offerings | Tagged barcelona, barcelona science park, biotech, cancer, capital cell, cebiotex, medtech, nanotech, spain